Harrow Health - Crunchbase Company Profile & Funding

Q: Who invested in Harrow Health?

Harrow Health has 3 investors including Oaktree Capital Management And SWK Funding.

Q: When was the last funding round for Harrow Health?

Harrow Health closed its last funding round on obfuscated from a Post-IPO Debt round.

Q: How much funding has Harrow Health raised to date?

Harrow Health has raised obfuscated.

Overview

Harrow Health

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Harrow Health

CB Rank

101848

Harrow Health is an eye health pharmaceutical company.

Founded

obfuscation

Public

Post-IPO Debt

Nashville, Tennessee, United States

251-500

www.harrowinc.com/

Biotechnology

Health Care

Medical

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Key People

Jamie Webb: Director of Communications and Investor Relations
Michael Biega: Vice President of Investor Relations and Communications
Past Role: Solebury Trout, Vice President

Details

Legal Name

Harrow Health, Inc.

Also Known As

Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc

Operating Status

Active

Stock Symbol

NASDAQ:HROW

Company Type

For Profit

Founders

Mark Baum

About the Company

Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health,

Phone Number

+1 615 733 4730

Contact Email

jwebb@harrowinc.com

Predictions & Insights

Growth Insight

See this Growth Insight

Harrow Health is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

IHEEZO

FDA-approved non-opioid ocular surface anesthetic for use in ophthalmic procedures.

MAQ-100 (MaQaid)

Preservative-free triamcinolone acetonide ophthalmic injection for visualization during vitrectomy, leveraging Japanese market approval data for U.S. submission.

Research & Development

Harrow Health is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Harrow Health	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Oaktree Capital Management	Yes	Post-IPO Debt - Harrow Health	Stephen DeNelsky
Oaktree Capital Management	Yes	Post-IPO Debt - Harrow Health	Stephen DeNelsky
Oaktree Capital Management	Yes	Post-IPO Debt - Harrow Health	Stephen DeNelsky
Oaktree Capital Management	Yes	Post-IPO Debt - Harrow Health	Stephen DeNelsky
Oaktree Capital Management	Yes	Post-IPO Debt - Harrow Health	Stephen DeNelsky